WO2004004811A1 - シリンジおよびプレフィルドシリンジ - Google Patents
シリンジおよびプレフィルドシリンジ Download PDFInfo
- Publication number
- WO2004004811A1 WO2004004811A1 PCT/JP2003/008413 JP0308413W WO2004004811A1 WO 2004004811 A1 WO2004004811 A1 WO 2004004811A1 JP 0308413 W JP0308413 W JP 0308413W WO 2004004811 A1 WO2004004811 A1 WO 2004004811A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pusher
- gasket
- outer cylinder
- syringe
- space
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31511—Piston or piston-rod constructions, e.g. connection of piston with piston-rod
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M2005/3117—Means preventing contamination of the medicament compartment of a syringe
- A61M2005/3121—Means preventing contamination of the medicament compartment of a syringe via the proximal end of a syringe, i.e. syringe end opposite to needle cannula mounting end
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M2005/3123—Details having air entrapping or venting means, e.g. purging channels in pistons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/3145—Filters incorporated in syringes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31511—Piston or piston-rod constructions, e.g. connection of piston with piston-rod
- A61M5/31515—Connection of piston with piston rod
Definitions
- the present invention relates to a syringe and a pre-loaded drug.
- the syringe is composed of an outer cylinder having a mouth portion with a reduced diameter on the distal end side, a gasket inserted into the outer cylinder from a base end opening of the outer cylinder, and a pusher (plunger rod) connected to the gasket.
- a pusher plunger rod
- a prefilled syringe in which a drug is stored (enclosed) in advance in this syringe is known.
- the drug is normally aseptically enclosed in a space (first space) on the tip side of the gasket maintained in a sealed state by a mouth seal.
- a prefilled syringe containing a drug solution as this drug usually, hold the outer cylinder with one hand and press the pusher with the other hand to push the gasket inside the outer cylinder toward the tip. Slide and drain (inject) the chemical from the mouth.
- the pusher When the drug is a powdered drug, usually, the pusher is once pulled, the gasket is slid in the proximal direction, and a liquid such as an infusion solution is sucked into the first space from the mouth of the outer cylinder. After dissolving the drug to make a drug solution, the pusher is pressed to discharge the drug solution.
- a syringe in which a cap is attached to a base end of the syringe in an unused state is also known.
- a syringe in which a cap is attached to a base end of the syringe in an unused state, is also known.
- a pre-filled syringe proposed in Japanese Patent Application Laid-Open No. Hei 7-244 638 in which a drug and a diluent are sealed in an outer cylinder and an inner cylinder (piston rod) and stored separately, The base ends of the outer cylinder and the inner cylinder are respectively sealed with caps.
- the inflow of outside air into the space on the proximal side from the pistons (gaskets) in the outer cylinder and the inner cylinder is blocked.
- the prefilled syringe of the type in which the outer cylinder and the inner cylinder are separately sealed with caps requires not only the work of removing each cap before use, but also the tip of the inner cylinder in the outer cylinder. It is necessary to attach another push rod (pusher) to the piston at the base end of the inner cylinder (see FIG. 2 in the above-mentioned publication), which has a disadvantage that the operation is complicated and troublesome.
- holes are provided in the outer cylinder and inner cylinder caps, It is conceivable that the pre-filled syringe is integrated by inserting the presser and the presser into the respective holes in an airtight manner.
- Syringes are packaged and shipped as described above.However, if the pusher is pushed by some force during transportation or storage and the gasket moves in the outer cylinder toward the distal end, the following adverse effects will occur. is there.
- the drug cake (a fixed-shaped lump of the freeze-dried product) may be broken by the gasket that has been moved, which may impair the aesthetics of the product.
- the powdered drug (or powdered drug from the beginning) may break into the gap between the outer peripheral surface of the gasket and the inner peripheral surface of the outer cylinder. . If a drug enters this gap, when the drug is administered using this syringe, the drug that has entered the gap remains without dissolving in the liquid inhaled into the outer cylinder, resulting in an irregular drug dose. There are cases.
- the pre-filled drug is a liquid (drug)
- the gasket tries to move in the distal direction, the pressure of the drug will increase, and the liquid will break through the sealing member at the mouth and leak, or the gasket will have an outer peripheral surface. In some cases, the gasket leaks from the inner peripheral surface of the outer cylinder to the proximal end of the gasket. Disclosure of the invention
- the present invention can broadly ensure hygiene in a syringe outer cylinder when not in use by itself, can be shipped without individually wrapped in a wrapping material, and can be used in chemical solutions during use.
- the purpose of the present invention is to provide a syringe structure and a pre-filled syringe which are excellent in operability such as discharge (injection) of a syringe.
- a first object of the present invention is to prevent foreign matter such as dust and dirt from entering the syringe, and to ensure hygiene in the syringe outer cylinder when not in use during storage or transportation. It is desirable to provide a syringe and a prefilled syringe which can preferably avoid bacterial contamination, can easily press or pull the pusher when using force, and can easily discharge (inject) a chemical solution. is there.
- a second object of the present invention is to provide a syringe and a prefilled syringe having a structure capable of reliably maintaining sterility in an outer cylinder even when an operation of pushing and pulling a pusher is performed.
- a third object of the present invention is to provide a syringe and a pre-filled syringe having a structure in which the gasket does not move in the direction of the tip even when the pusher is pressed when not in use, and which can stably maintain the arrangement of the pusher at the time of shipping. It is in.
- the first object is provided by a sealing member arranged at a base end opening of an outer cylinder, and a pusher having ventilation means slidably fitted in a central through hole of the sealing member.
- a sealing member arranged at a base end opening of an outer cylinder
- a pusher having ventilation means slidably fitted in a central through hole of the sealing member.
- it comprises a cylindrical outer cylinder, a gasket disposed in the outer cylinder and dividing the space inside the outer cylinder into a distal end side and a proximal end side, and a pusher connected to the gasket.
- At least the gasket connection side body portion is formed into a cylindrical shape which is in close contact with the hole of the sealing member, and ventilation means as described later is provided along the axial direction, and the outer cylinder
- a first aspect of the present invention provides a syringe structure in which a sealing member having an insertion hole at the center is disposed at the base end opening, and the pusher is slidably fitted into the through hole.
- the venting means may include a groove, a slit or a ridge provided on the outer periphery of a base end side body portion (solid) of the pusher to provide a gap between the insertion member and the insertion hole.
- a structure in which the pusher is formed as a hollow cylinder in the entire axial direction can be given.
- the pusher In the syringe having such a ventilation means, the pusher is moved forward (pressed) or retracted, so that the proximal end side of the gasket in the outer cylinder formed by the inner peripheral surface of the outer cylinder and the outer peripheral surface of the pusher. Can be opened or closed.
- the distal end or the proximal end opening of the pusher is provided with an end of an air passage or a filter, in particular, a sterilization filter.
- a finger contact portion of the pusher is formed as a separate member (operating portion) from the pusher body, and the operating portion is engaged with the pusher body so as to be able to expand and contract.
- a syringe structure for stopping the distal end of the operation unit at the base end of the outer cylinder.
- the present invention provides a prefilled syringe in which a drug is stored in a syringe having each of these structures.
- the first object is achieved by the present invention of the first embodiment shown in the following (1) to (6).
- An outer cylinder having an opening at the distal end through which liquid can enter and exit, a gasket slidable in the outer cylinder, and an operation for moving the gasket in the longitudinal direction of the outer cylinder connected to the gasket.
- a presser a ventilation member formed in the presser, a sealing member that seals a base end opening of the outer cylinder, and has a through hole that penetrates the presser, A first space surrounded by the outer cylinder and the gasket positioned on the distal end side of the gasket, and the outer cylinder positioned on the base end side of the gasket; the gasket; A second space surrounded by the member and
- the second space Before pressing the pusher in the distal direction, the second space is kept in a state of being blocked from outside air (sealed state), and when the pusher is pressed in the distal direction, the ventilation means A syringe configured to allow outside air to flow into the second space.
- the moving distance of the pusher from the start of the pushing operation of the pusher in the tip direction to the start of the inflow of the outside air into the second space is 2 to 10 mm.
- a ventilation means as described in the above (3) is provided in a syringe structure including a ventilation path inside the pusher.
- the following inventions (7) to (12) in which an end of an air passage or a filter, particularly a sterilization filter, is disposed at a distal end or a proximal end opening of a pusher are provided.
- the ventilating means has a filter at the end or in the middle of the ventilation path.
- a gasket that is slidably disposed in the outer cylinder and partitions the inner space of the outer cylinder into a distal end side and a proximal end side;
- a pusher connected to the gasket and configured to move the gasket in a longitudinal direction of the outer cylinder; and a second enclosure surrounded by the outer cylinder, the gasket, and the sealing member located at the base end side of the gasket. And a vent formed inside the pusher so as to communicate the space with the outside, and a filter installed so as to close the vent, and through which gas passes but bacteria do not pass.
- the outer peripheral surface slides while being in close contact with at least a part of the insertion hole, and outside air flows into the space through the ventilation path. Syringe.
- the gasket has a hollow portion formed at the base end surface thereof, and has a head portion inserted into the hollow portion at a distal end portion of the pusher.
- the portion of the sealing member that comes into contact with the pusher is configured by at least one ring-shaped protrusion that projects toward the center from the inner surface of the through hole.
- the syringe according to any one of (14).
- the syringe structure in which the gasket does not move in the distal direction even when the pusher is pressed when not in use that is, the second invention is described above in combination with the first invention (19) to (22).
- the following (23) to (26), and preferably further (27) are also provided.
- an outer cylinder having an opening through which liquid can enter and exit on the distal end side; a gasket disposed slidably in the outer cylinder to partition an inner space of the outer cylinder into a distal end side and a proximal end side; A pusher connected to the gasket and operating to move the gasket in the longitudinal direction of the outer cylinder,
- the pusher has a pusher main body, and a pusher operating unit provided at a base end side of the pusher main body so as to be movable in a longitudinal direction of the pusher,
- the pusher operating portion has a contact portion that can contact a base end portion of the outer cylinder or a portion near the base end portion when the pusher length is short, In a state where the length of the pusher is short, the gasket is pushed to the distal end of the body of the outer cylinder by the abutting portion abutting on the base end of the outer cylinder or a part near the base.
- the syringe is characterized in that, by setting the length of the pusher to be long, the gasket can be pushed to the tip of the body of the outer cylinder.
- One of the pusher body and the pusher operating portion has a resilient piece and a convex portion formed on a side opposite to a base of the elastic piece, and the other has the convex portion.
- the outer cylinder has a plate-shaped outer cylinder flange at a base end thereof, and the contact portion abuts on a base end surface of the outer cylinder flange when the pusher is short in length.
- the syringe according to any one of the above (23) to (25), which is in contact with the syringe.
- a guide surface for guiding the convex portion into the concave portion is formed near the concave portion, and the pusher operating portion is moved in the proximal direction relative to the pusher main body.
- the mouth is usually sealed with an openable film.
- the membrane is opened by piercing with a needle.
- each syringe having the above structure A space surrounded by the outer cylinder and the gasket located on the tip side of the gasket (No.
- a prefilled syringe containing a pre-stored drug is provided.
- FIG. 1 is a partial longitudinal sectional view showing a first embodiment (disassembled state) of a syringe of the present invention (first invention).
- FIG. 2 (a) is a partial longitudinal sectional view showing a first embodiment (in a pre-filled syringe assembled state) of the syringe of the present invention (first invention), and FIG. 2 (b) is a sectional view taken along line bb in (a). It is a cross-sectional view of the pusher main body part along.
- FIG. 3 is a partial longitudinal sectional view showing an operation state when the prefilled syringe shown in FIGS. 1 and 2 is used.
- FIG. 4 is a partial longitudinal sectional view showing an operation state when the prefilled syringe shown in FIGS. 1 and 2 is used.
- FIG. 5 is a partial longitudinal sectional view showing an operation state when the prefilled syringe shown in FIGS. 1 and 2 is used.
- Fig. 6 (a) is a partial longitudinal sectional view showing a second embodiment (assembled state) of the prefilled syringe of the present invention (first invention), and (b) is along the line bb in (a). It is a cross-sectional view of a pusher main body.
- FIG. 7A shows a third embodiment of the prefilled syringe of the present invention (first invention). It is a fragmentary longitudinal cross-sectional view showing (assembled state), and (b) is a cross-sectional view of the pusher main body along the line bb in (a).
- FIG. 8A is a partial longitudinal sectional view showing a fourth embodiment (assembled state) of the prefilled syringe of the present invention (first invention), and FIG. 8B is a sectional view taken along line b—b in FIG. It is a cross-sectional view of a pusher main body.
- FIG. 9 is a longitudinal sectional view showing a disassembled state of the embodiment of the prefilled syringe according to the present invention (second invention).
- FIG. 10 (a) is a partial perspective view of the presser body from the direction of arrow a in Fig. 9, (b) is a cross-sectional view taken along the line bb in Fig. 9, and (c) is FIG. 4 is a cross-sectional view taken along line c-c of FIG.
- FIG. 11 is a longitudinal sectional view showing an assembled state (a state before use) of the prefilled syringe shown in FIG.
- FIG. 12 (a) is a longitudinal sectional view showing a state when the prefilled syringe shown in FIG. 9 and FIG. 11 is used, and (b) is a transverse sectional view taken along the line bb in (a). .
- FIG. 13 is a longitudinal sectional view showing a state when the prefilled syringe shown in FIGS. 9 and 11 is used.
- FIG. 14 is a longitudinal sectional view showing a state when the prefilled syringe shown in FIGS. 9 and 11 is used.
- FIG. 15 is a partial longitudinal sectional view showing a disassembled state of the embodiment of the prefilled syringe according to the present invention (first and second inventions).
- FIG. 16 is a longitudinal sectional view showing an assembled state (a state before use) of the prefilled syringe shown in FIG.
- FIG. 17 is a longitudinal sectional view showing an assembled state (a state in use) of the prefilled syringe shown in FIG.
- FIG. 18 is an enlarged longitudinal sectional view showing the vicinity of a gasket in the prefilled syringe shown in FIG.
- FIG. 19 is an enlarged longitudinal sectional view showing the vicinity of the base end of the outer cylinder in the prefilled syringe shown in FIG. BEST MODE FOR CARRYING OUT THE INVENTION
- FIG. 1 disassembled state
- FIG. 2 assembled state showing a prefilled siridine which is an embodiment of the present invention.
- the syringe 1 is disposed inside the outer cylinder 2 having a cylindrical outer cylinder 2 having an opening (reduced diameter portion) 22 for discharging the liquid from the distal end opening 202 and for injecting the Z.
- a gasket 3 that divides the space inside 2 into a distal end (first space 27) and a proximal end (second space 26), and slides the gasket 3 toward the distal end Z in the outer cylinder 2.
- a pusher 4 coupled to the gasket for movement.
- the syringe according to the first aspect of the present invention includes a sealing member 5 disposed at a base end opening 201 of an outer cylinder 2, and a presser 4 slides into an insertion hole 51 of the sealing member 5. It is inserted as much as possible.
- the pusher 4 has a cylindrical portion 40 at least at the distal end side (on the side connected to the gasket 3) that closely slides with the through hole 51 of the sealing member 5, and is provided along the axial direction thereof.
- ventilation means 42 of various shapes. Due to such advance (pressing force) of the pusher 4, a pressure is generated between the ventilation means 42 of the pusher 4 and the sealing member 5 (insertion hole 51).
- the internal ventilation path of the hollow pusher 4 and the second space 26 communicate with each other, and the second space 26 in the outer cylinder 2 communicates with the outside air.
- FIGS. 1 to 5 show a prefilled syringe (hereinafter sometimes simply referred to as “syringe”) according to a first embodiment of the first invention.
- Fig. 1 is a partial longitudinal sectional view showing a disassembled state of the syringe before filling the medicine for explaining the components of the syringe
- Fig. 2 (a) is a partial longitudinal sectional view showing an assembled state (prefilled syringe) after filling the medicine
- (B) is a cross-sectional view of the pusher.
- 3 to 5 are partial longitudinal sectional views showing the operation when the prefilled syringe shown in FIG. 2 is used.
- the upper side in the figures is the “base end” side of the syringe
- the lower side is the “distal end” side.
- the syringe 1 of the present embodiment includes an outer cylinder (syringe outer cylinder) 2, a gasket 3 slidable in the outer cylinder 2, and a pusher (plunger) for moving the gasket 3 in the longitudinal direction of the outer cylinder 2.
- the gasket 3 is connected to the tip of the pusher 4.
- the outer cylinder 2 is formed of a member having a bottomed cylindrical shape (cylindrical shape) 20 having a bottom portion 21 on the distal end side, and a central portion of the bottom portion 21 is provided with a body portion 20 of the outer cylinder 2.
- a reduced diameter portion 22 having a reduced diameter is integrally formed.
- the distal end opening 202 of the reduced diameter portion 22 forms an opening through which liquid can enter and exit.
- a male screw (luer lock screw) (not shown) may be formed on the outer periphery of the base end of the reduced diameter portion 22.
- a membrane 11 made of a flexible material is attached as a sealing member to the distal end opening 202 of the reduced diameter portion 22 to hermetically seal the lumen 23 of the reduced diameter portion 22. I have.
- a cap 12 is fitted and fixed to the outside of the reduced diameter portion 22.
- the cap 12 is used in connection with a holder 7 described later, and also functions as a connection portion with the holder 7.
- An opening 12 1 is formed at the tip of the cap 12, and the outer peripheral portion of the membrane 11 is held between the edge of the opening 12 1 and the tip surface of the reduced diameter portion 22. Thereby, the membrane 11 is fixed in an airtight (liquid tight) manner. It is preferable that the reduced diameter portion 22, the membrane 11, and the cap 12 are bonded or fused to each other with an adhesive.
- the membrane 11 can be pierced by a body such as a double-ended needle described later.
- the form of the membrane 11 is not limited to the membrane shape as long as it can be stimulated by the needle, and may be, for example, a block shape (plug).
- the material exemplified later as a constituent material of the gasket 3 can be used.
- a plate-like flange 24 is integrally formed on the outer periphery of the proximal end of the outer cylinder 2.
- the operation can be performed by putting a finger on the flange 24.
- a locking portion for locking the sealing member 5 to an outer edge portion of a fixing portion 54 of the sealing member 5, which will be described later. 4a is formed.
- the locking portion 24 a is formed in a ring shape over the entire circumference of the flange 24, but is not limited thereto, and may be, for example, a partially formed member such as a claw member. May be.
- Examples of the constituent material of the outer cylinder 2 include polyvinyl chloride, polyethylene, polypropylene, cyclic polyolefin, polystyrene, poly (4-methylpentene1-1), polycarbonate, acrylic resin, acrylic nitrile and butadiene and styrene.
- Polymers polyesters such as polyethylene terephthalate and polyethylene naphthalate, butadiene-styrene copolymers, polyamides (for example, nylon 6, nylon 6.6, nylon 6.10, nylon 12), polysulfone, polyether
- Various resins such as sulfone, polyether ether ketone, and ethylene-bier alcohol copolymer system are exemplified.
- resins such as polypropylene, cyclic polyolefin, polyester, and poly- (4-methylpentene-1) are preferable in terms of easy molding.
- the constituent material of the outer cylinder 2 is substantially transparent in order to secure the visibility of the inside.
- a scale 29 is formed on the outer peripheral surface of the body 20 of the outer cylinder 2 (see FIG. 1). Thereby, the amount of the liquid (infusion 82, medicinal liquid 110, etc.) in the syringe 1 can be grasped.
- a gasket 3 made of an elastic material is accommodated in the outer cylinder 2.
- a plurality of ring-shaped convex portions 31 and 32 are formed all around.
- the outer diameter of the convex portions 31 and 32 in the natural state of the gasket 3 is larger than the inner diameter of the outer cylinder 2, and when the gasket 3 is inserted into the outer cylinder 2, the characteristic of the gasket 3 is As a result, the outer peripheral portion slides while being in close contact (pressure contact) with the inner peripheral surface 200 of the outer cylinder 2, thereby maintaining airtightness (liquid tightness) more reliably and improving slidability. Can be achieved.
- two convex portions 31 and 32 are formed along the longitudinal direction of the gasket 3.
- the convex portions 31 and 32 are formed on the base end surface 36 side and the distal end surface 35 side of the gasket 3, respectively.
- the base end side of the projection 32 on the gasket front end side preferably has a tapered surface whose outer diameter gradually increases toward the front end.
- the formation position, the number, the cross-sectional shape, and the like of the convex portions 31 and 32 are not limited thereto.
- the gasket 3 is formed with a hollow portion 33 which is open to a base end surface 36 thereof.
- a head portion of a pusher 4 described later is inserted (screwed) into the hollow portion 33.
- a female screw 34 is formed on the inner surface of the hollow portion 33.
- the material of the gasket 3 is not particularly limited, but includes, for example, various rubber materials such as natural rubber, butyl rubber, isoprene rubber, butadiene rubber, styrene-butadiene rubber, silicone rubber, polyurethane, polyester, and poly.
- various rubber materials such as natural rubber, butyl rubber, isoprene rubber, butadiene rubber, styrene-butadiene rubber, silicone rubber, polyurethane, polyester, and poly.
- examples include various thermoplastic elastomers such as amide-based, polyolefin-based, and polystyrene-based elastomers, and elastic materials such as a mixture thereof.
- the gasket 3 only needs to have at least an outer peripheral portion made of the above-described elastic material.
- the gasket 3 has a core (not shown) made of a resin material. May be configured such that an elastic material is disposed to cover the elastic member.
- the female screw 34 is formed in the core.
- a pusher 4 for moving the gasket 3 in the longitudinal direction in the outer cylinder 2 is connected (mounted) to the gasket 3.
- the presser 4 has a rod-shaped, preferably round rod-shaped main body 40, A flange-shaped (plate-shaped) finger pad 45 is formed at the base end of the zero. By pressing the finger contact portion 45 with a finger or the like, the pusher 4 is moved in the distal direction.
- the main body portion 40 has a sliding portion 41 that slides while the substantially outermost peripheral surface of the substantially cylindrical shape is in close contact with convex portions 52 a and 52 b of the sealing member 5 described later.
- the sliding portion 41 has a circular cross section of a solid round bar shape (or a hollow round bar shape).
- a groove (air passage) 4 2 1 is provided in the sliding portion 41 of the main body 40 as a ventilation means 42 for allowing ventilation between the outside of the syringe 1 and a second space 26 described later. It is formed.
- This groove 4 21 extends along the longitudinal direction of the main body 40. It is open to the outer peripheral surface of the pusher 4.
- three grooves 421 are formed along the circumferential direction of the main body 40.
- the cross-sectional shape of the groove 421 may be any shape such as a U-shape, a V-shape, and a U-shape.
- Each groove 421 may be formed independently or may be partially connected.
- the area where the groove 4 21 is formed in the longitudinal direction of the presser 4 is preferably determined as follows.
- the base end 4 21 a of the groove 4 21 is located at or near the base end of the main body 40 of the pusher 4.
- the tip 4 2 1 b of the groove 4 2 1 is in the unused state of the syringe 1, that is, the state before the pusher 4 is pressed in the tip direction (hereinafter simply referred to as “the operation state before operation”).
- the position is a position closer to the base end than the convex portion 52 b of the sealing member 5 described later.
- the distal end 4 221 b of the groove 421 is located near the base end side of the convex portion 52 a of the sealing member 5.
- the second space 26 is kept in a state of being cut off from the outside air (sealed state). As a result, it is possible to prevent foreign matter such as dust and dirt from entering the second space 26 together with the outside air, and prevent bacteria from entering the second space 26, thereby maintaining hygiene.
- the number and the location of the grooves 421 and the shape of the grooves 421 are not limited to those described above.
- a male screw 44 that can be screwed with the female screw 34 on the inner surface of the hollow portion 33 of the gasket 3 is formed. By screwing the male screw 44 with the female screw 34, the gasket 3 and the pusher 4 are connected (see FIG. 2).
- Examples of the constituent material of the presser 4 include polysalt ⁇ vinyl, polyethylene, polypropylene, polystyrene, poly (4-methylpentene-1), polycarbonate, acrylic resin, acrylic nitrile-butadiene-styrene copolymer, polystyrene Polyesters such as polyethylene terephthalate, polyethylene naphthalate, etc., butyl-styrene copolymers, polyamides (eg, nylon 6, nylon 6.6, nylon 6.10, nylon 12), polysulfone, polyethersulfone And various resins such as polyether ether ketone and ethylene-vinyl alcohol copolymer. Among these, resins such as polypropylene, polyester, and poly (4-methylpentene-11) are preferred because they are easy to mold.
- connection between the gasket 3 and the pusher 4 is made by the screwing structure (an example of a mechanism having no play), these connections can be reliably performed, and the pushing can be performed.
- the gasket 3 and the pusher 4 do not separate from each other with the operation of the pusher 4, and the pusher 4 can be easily attached to and detached from the gasket 3.
- connection structure between the gasket 3 and the pusher 4 may be a structure other than screwing, for example, a mechanism having no play such as adhesion, fixation such as fusion, and fitting, or A mechanism having play such as loose fit may be used.
- a sealing member 5 for sealing the proximal opening 201 of the outer cylinder 2 is attached to the proximal end side of the outer cylinder 2.
- the sealing member 5 is entirely made of an elastic material, and has a substantially cylindrical main body 50. At the center of the main body 50, an insertion hole 51 that passes through the main body 40 of the pusher 4 is formed. Further, a flange-shaped (plate-shaped) fixing portion 54 is formed on the outer peripheral portion of the main body 50 of the sealing member 5.
- the second space 26 can maintain the air-tightness (airtightness) with the outside air.
- two convex portions 52 a and 52 b are formed at predetermined intervals along the axial direction of the through hole 51 of the sealing member 5.
- the formation position, the number, the cross-sectional shape, the formation interval, and the like of the protrusions 52 a and 52 b are not limited to those illustrated.
- the main body 50 is fitted into the base end opening 201 of the outer cylinder 2.
- the outer peripheral surface of the main body 50 is in close contact with the inner peripheral surface 200 of the outer cylinder 2, and the outer edge of the fixing portion 54 is sandwiched and fixed by the locking portion 24 a, so that the fixing portion 5 4 Of the flange 24 comes into close contact with the proximal end of the flange 24 (see Fig. 2).
- the convex portions 52 a and 52 b of the sealing member 5 are in close contact with the sliding portion 41 of the pusher 4.
- the sealing member 5 also has a function of preventing the gasket 3 from coming off the outer cylinder 2.
- the sterility in the outer cylinder 2 can be maintained at a higher level. Also, when assembling the syringe 1, even if the syringe 1 is packaged in a non-sterile environment after attaching the pusher 4, sterility inside the syringe can be maintained, so that the sterilization of the packaging process is not required, and therefore, manufacturing and assembly There is also an advantage that it is advantageous.
- the constituent material of the sealing member 5 is not particularly limited, and includes, for example, various rubber materials such as natural rubber, butyl rubber, isoprene rubber, butadiene rubber, styrene-butadiene rubber, silicone rubber, polyurethane, polyester, Elastic materials such as various thermoplastic elastomers such as polyamide, polyolefin, and polystyrene, or mixtures thereof.
- thermoplastic polyurethane elastomers for example, Elastran® 680, etc., manufactured by Takeda Birdie Urethane Industry Co., Ltd.
- polystyrene-based elastomers for example, manufactured by Mitsubishi Chemical Corporation: Lavalon MJ430, etc.
- the gasket 3 it is preferable that the surface 36 be located at a distance from the tip end surface 55 of the sealing member 5 by a certain distance.
- the volume of the second space 26 can be secured to some extent, and the pressing operation of the pusher 4 can be easily started (with a relatively small force). Then, it is possible to easily achieve the pressure difference P i — P 2 described later.
- a chemical solution 110 is stored in advance in a first space 27, which is a space surrounded by the outer cylinder 2 and the gasket 3, and is located on the tip side of the gasket 3 ( See Figure 2).
- Such a drug solution 110 include vitamin preparations (multivitamin preparations), various amino acids, antithrombotic agents such as heparin, insulin, antibiotics, antitumor agents, analgesics, inotropic agents, and intravenous injection.
- antithrombotic agents such as heparin
- insulin antibiotics, antitumor agents
- analgesics such as heparin
- inotropic agents such as heparin
- intravenous injection such as heparin, insulin, antibiotics, antitumor agents, analgesics, inotropic agents, and intravenous injection.
- Anesthetics Bo Parkinsonian agents, ulcer treatment agents, adrenocortical hormonal agents, arrhythmic agents, correction electrolytes, and the like. Needless to say, the present invention is not limited to these.
- a solid drug for example, a drug such as a powder (granule) or a freeze-dried product may be stored.
- a liquid such as an infusion is introduced into the first space 27 by, for example, performing an operation of once pulling the pusher 4 in the proximal direction, and dissolving the drug in the introduced liquid to dissolve the drug solution. After that, press the pusher 4 in the direction of the tip to discharge (inject) this chemical.
- the method described below is an example in which a syringe with a double-ended needle is connected to the syringe 1 and a drug solution is co-injected into an infusion container.
- the holder 7 connected to the syringe 1 is a cylindrical holder with a bottom—the main body 7 1 and double-ended needles (needle tubes) 7 with sharp needle tips 73 and 74 at both ends. 2 and a hub (support member) 75 that supports the double-ended needle 72.
- the double-ended needle 72 is fixed to a hub 75, and the hub 75 is attached to the center of the bottom of the holder body 71 by screwing.
- the infusion container 8 has, for example, a bottle (bottle) shape or a bag shape, and contains an infusion solution 82 in a liquid-tight manner.
- a stopper 81 made of an elastic material is attached to the mouth of the infusion container 8.
- the infusion container 8 is liquid-tightly sealed by the stopper 81.
- the plug 81 can be pierced by a double-ended needle 72 or another needle tube such as a bottle needle. When the needle tube is pulled out, the piercing hole is closed by self-closure and liquid tightness is secured.
- the holder 17 and the infusion container 8 as described above are prepared. First, the needle tip 74 of the holder 17 is inserted into the plug 81 of the infusion container 8 (see FIG. 3).
- the holder body 71 of the holder 7 is fitted (covered) to the cap 12.
- the needle tip 73 penetrates the membrane 11 and enters the lumen 23 of the reduced diameter portion 22 (see FIG. 3).
- the first space 27 of the syringe 1 communicates with the internal space of the infusion container 8 via the double-ended needle 72.
- the piercing of the needle tip 74 into the plug 81 and the piercing of the needle tip 73 into the membrane 11 may be performed in the reverse order.
- the leading end 42 lb of the groove 4 21 formed in the pusher 4 is located near the convex portion 52 a of the sealing member 5.
- the second space 26 is still in a state of being shut off from the outside air (sealed state) (see FIG. 3).
- the pressure in the second space 26 is a negative pressure (a pressure lower than the atmospheric pressure).
- the groove 4 2 1 is inserted into the negative space of the second space 26. Outside air flows in (see Fig. 4). Thus, the second space 26 returns to the atmospheric pressure.
- the pressure in the second space 26 in the pre-operation state is set to P i [atmospheric pressure], the pressing operation toward the distal end of the pusher 4 is started, and the pressure immediately before the outside air flows into the second space 26 ( That is, in the present embodiment, when the pressure in the second space 26 is P 2 [atmospheric pressure] when the tip 4 2 1 b of the groove 4 2 1 is at the position of the convex portion 5 2 b, pressure difference -... P 2 is 0 but preferably not more than 9 atm, 0 1 to 0 and more favorable preferable 7 atm. If this pressure difference is too large, a large force is required for the pressing force of the pusher 4 in the initial stage of the pressing operation of the pusher 4, and there is a possibility that the initial operability may not be sufficiently improved.
- the pressure may be equal to the atmospheric pressure or a pressure higher than the atmospheric pressure (the second space 26 is previously pressurized). In the latter case, the pressing operation of the pusher 4 in the initial stage can be performed more easily (with a small force). Further, from the start of the pressing operation of the pusher 4 toward the distal end, until the start of the flow of the outside air into the second space 26 (in the present embodiment, the distal end 4 2 of the groove 4 2 1 from the pre-operation state).
- the moving distance of the pusher 4 (when 1b exceeds the convex portion 52b) is preferably 2 to 10 mm, and more preferably 2 to 5 mm.
- the presser 4 is pressed in the tip direction.
- the medicinal solution 110 in the first space 27 passes through the double-ended needle 72 and is gradually injected into the infusion 82 of the infusion container 8 and blended.
- the pressing movement of the pusher 4 is performed until the distal end surface 35 of the gasket 3 contacts (or approaches) the bottom portion 21 of the outer cylinder 2 (see FIG. 5).
- the amount of the chemical solution 110 remaining in the syringe 1 can be reduced as much as possible, and the chemical solution 110 can be mixed (injected) into the infusion solution 82 without waste.
- the volume of the second space 26 gradually increases with the movement of the gasket 3 toward the distal end due to the pressing of the pusher 4, but at this time, the groove 4 2 is provided in the second space 26.
- the outside air flows in through 1 (see FIG. 5), and the second space 26 maintains the atmospheric pressure.
- Fig. 6 (a) is a longitudinal sectional view showing a second embodiment of the prefilled syringe according to the first invention, and (b) is a main body 4 of the pusher 4 along the line b-b in (a).
- FIG. In the following description of the second embodiment, description of the same matters as in the above-described first embodiment will be omitted, and differences will be mainly described.
- the syringe 1 of the second embodiment is different from the first embodiment in the configuration of the ventilation means.
- the ventilation means 42 in the syringe 1 of the second embodiment is constituted by a slit (vent path) 42 formed in the main body 40 of the pusher 4.
- the slits 422 extend along the longitudinal direction of the main body 40 and open to the outer peripheral surface of the main body 40.
- the preferred formation area of the slits 42 in the longitudinal direction of the presser 4, that is, the positions of the base end 42 a and the distal end 42 b of the slit 42 are the same as the grooves 42 described in the first embodiment. Similar to those of one.
- FIG. 7A is a longitudinal sectional view showing a third embodiment of the prefilled syringe according to the first invention
- FIG. 7B is a longitudinal sectional view of the main body 4 of the pusher 4 along the line b—b in FIG. 7A.
- FIG. 7A In the following description of the third embodiment, a description of the same matters as in the first embodiment will be omitted, and differences will be mainly described.
- the syringe 1 of the third embodiment is different from the first embodiment in the configuration of the ventilation means.
- the ventilation means 42 in the syringe 1 of the third embodiment includes a lumen (air passage) 423 formed along the longitudinal direction inside the main body 40 of the pusher 4; A side hole 424 is provided at the distal end and opens to the outer peripheral surface of the main body 40.
- the formation position of the side hole 424 is a position between the convex portion 52a and the convex portion 52b of the sealing member 5 in the state before the operation.
- the position where the side hole 424 is formed may be the same as the position where the tip 4221b of the groove 421 in the first embodiment is formed.
- the base end of the lumen 423 penetrates through the finger rest part 45 and opens to the base end face of the finger rest part 45.
- a filter 9 is installed near the base end of the lumen 423 so as to close the ventilation path of the lumen 423.
- the pusher 4 is pressed and moved in the distal direction, and the side hole 4 2 4 is moved beyond the projection 5 2 b into the second space 2 6. Once inside, the outside air passes through the filter 9 and is introduced into the second space 26 through the lumen 43 and the side hole 424 sequentially.
- the filter 9 examples include a filter that allows air to pass through but does not allow foreign substances such as dust, dust, and dust to pass through, and a filter that allows air to pass but does not allow liquid to pass. If the filter 9 is a filter that allows air to pass through but does not allow foreign substances such as dust, dust, and dust to pass through and does not allow bacteria to pass through (the bacteria-impermeable filter 1), It is preferable because it can prevent the invasion of bacteria.
- Examples of such a filter 9 include a porous sintered body such as a polyolefin sintered body, a hydrophobic non-woven fabric, a hydrophobic membrane filter, and the like. No.
- the selection of the function of the filter 9 can reliably prevent foreign substances from entering the second space 26 and further prevent bacteria from entering.
- the pusher 4 and the gasket 3 are reciprocated (for example, when the liquid is sucked into the first space 27 and the liquid is discharged from the first space 27 at least once).
- the sterility of the first space 27 and the second space 26 can be maintained.
- the installation position of the filter 9 is not limited to the position shown in FIG. 7, and may be near the side hole 424 in the middle of the lumen 423. In addition, it is acceptable that such a fillet 9 is not installed.
- FIG. 8A is a longitudinal sectional view showing a fourth embodiment of the prefilled syringe according to the first invention
- FIG. 8B is a longitudinal sectional view of the main body 4 of the pusher 4 along the line b—b in FIG. FIG.
- a description of the same matters as in the first embodiment will be omitted, and differences will be mainly described.
- the syringe 1 of the fourth embodiment is different from the first embodiment in the configuration of the ventilation means.
- the ventilation means in the syringe 1 of the fourth embodiment is constituted by ridges (ribs) 425 formed on the outer peripheral surface of the main body 40 of the pusher 4.
- the ridges 425 extend along the longitudinal direction of the main body 40 and have a cross-sectional shape of, for example, a mountain shape.
- the preferred formation region of the ridges 425 with respect to the longitudinal direction of the presser 4, that is, the positions of the base end 425 a and the tip 425 b of the ridges 425 are the grooves described in the first embodiment. Similar to those of 4 2 1.
- the distal end 4 25 b of the convex ridge 4 25 firstly moves the convex portion 52 a into a part.
- the tip 4 2 5 b of the ridge 4 2 5 partially expands the ridge 5 2 b to expand the ridge 4 2 5
- a gap is formed in the vicinity of the root of the space, whereby outside air flows into the negative space of the second space 26 via the gaps of the convex portions 52a and 52b.
- the number of the convex ridges 425 is one, but two or more ridges may be formed.
- a syringe and a prefilled syringe according to the second embodiment of the present invention will be described with reference to FIGS.
- FIG. 9 is a longitudinal sectional view showing a disassembled state of the syringe (prefilled syringe) according to the second embodiment of the present invention
- FIG. 10 (a) is a pusher viewed from the direction of arrow a in FIG.
- FIG. 10B is a partial perspective view of the main body
- (b) is a cross-sectional view along line bb in FIG. 9,
- (c) is a cross-sectional view along line c-c in FIG.
- Fig. 11 is a longitudinal sectional view showing the assembled state (before use) of the prefilled syringe shown in Fig. 9, and Figs. 12 to 14 are the use of the prefilled syringe shown in Figs. 9 and 11, respectively.
- the syringe 1 of the present embodiment is a pre-filled syringe in which a medicine 100 is previously aseptically stored in a first space 27 of an outer cylinder 2, and includes an outer cylinder (syringe outer cylinder) 2 and an outer cylinder 2.
- the gasket 3 includes a gasket 3 slidable in the cylinder 2 and a pusher (plunger rod) 4 for moving the gasket 3 in the longitudinal direction of the outer cylinder 2.
- the structure of the outer cylinder 2 is the same as that of the first invention except that the base end flange 24 is formed of a small flange, and the plate-shaped outer cylinder flange 25 is formed separately from the body 20. There is a cap 12 fitted with a membrane 11 attached to the tip of the mouth (reduced diameter portion) 22 of the outer cylinder 2 and fixed.
- the outer cylinder 2 be substantially transparent in order to secure the visibility inside.
- a scale (not shown) is formed on the outer peripheral surface of the body 20 of the outer cylinder 2 so that the amount of liquid (infusion, chemical solution, etc.) in the syringe 1 can be grasped. Is preferred.
- the base flange 24 of the trunk 20 of the outer cylinder 2 is formed of a small flange, and a plate-shaped outer cylinder flange 25 formed separately from the trunk 20 is attached (fixed).
- the outer cylinder flange 25 can be formed of the same material as the outer cylinder 2.
- the method of fixing the outer cylinder flange 25 to the body part 20 is not particularly limited. For example, a claw formed on the base flange (small flange) 24 of the outer cylinder 20 and a claw formed on the outer cylinder flange 25 Part 2 52 (see Fig.
- the outer cylinder flange 25 may be formed integrally with the body 20.
- the operation can be performed by putting a finger on the outer cylinder flange 25.
- a circular hole 2 51 through which the pusher 4 is inserted is formed in the center of the outer cylinder flange 25.
- the inner diameter of the hole 25 1 is smaller than the inner diameter of the body 20.
- the outer cylinder flange 25 also has a function of preventing a gasket 3 and a pusher 4 described later from coming off the outer cylinder 2.
- a gasket 3 made of an elastic material is stored in the body 20 of the outer cylinder 2.
- the outer diameter of the gasket 3 in the natural state is larger than the inner diameter of the body 20, and when the gasket 3 is inserted into the body 20, the outer periphery of the gasket 3 is elastic due to the elasticity of the gasket 3. Adhesion (pressure contact) to the inner peripheral surface 200 of 20.
- a plurality of ring-shaped convex portions 31 and 32 are formed all around.
- the protrusions 31 and 32 slide while being in close contact with the inner peripheral surface 200 of the body portion 20, so that airtightness (liquid tightness) is more reliably maintained and slidability is improved. Improvement can be achieved.
- two convex portions 31 and 32 are formed along the longitudinal direction of the gasket 3. That is, the convex portions 31 and 32 are formed at the base end and the distal end of the gasket 3, respectively.
- the formation position, the number, the cross-sectional shape, and the like of the convex portions 31 and 32 are not limited thereto.
- the gasket 3 is formed with a hollow portion 33 which is open at the base end surface.
- the head portion 43 of the pusher 4 described later is inserted (fitted) into the hollow portion 33.
- a medicine 100 is stored in advance in a space 27 surrounded by the outer cylinder 2 located at the distal end side of the gasket 3 and the gasket 3. .
- the drug 100 may be a liquid or a solid (solid, powdered, or granular), but in the present embodiment, the solid drug 100 is stored.
- the drug 100 is obtained by freeze-drying a drug solution injected into the syringe 1 from the reduced diameter portion 22 and is solidified in a certain shape to form a drug cake.
- drugs 100 include vitamins (multivitamins), various amino acids, antithrombotics such as heparin, insulin, antibiotics, antitumor agents, analgesics, inotropics, and intravenous injections. Anesthetics, antiparkinson agents, ulcer treatment agents, adrenocortical hormone agents, arrhythmia agents, correction electrolytes, proteolytic enzyme inhibitors, tropoxane synthesis inhibitors, and the like. It goes without saying that the present invention is not limited to these.
- a pusher 4 that moves the gasket 3 in the longitudinal direction within the body portion 20 of the outer cylinder 2 is connected (mounted) to the gasket 3.
- the pusher 4 includes a pusher body 40 and a pusher operation that is installed at the base end side of the pusher body 40 so as to be movable in the longitudinal direction of the pusher 4. 6 and its length (total length) is variable (expandable).
- the presser body 40 has a cylindrical portion 41. At the tip of the cylindrical portion 41, a first flange 43a having a flange shape and a first flange 43a are formed. A second flange 43b located near the base end is formed.
- the head portion 43 is constituted by the cylindrical portion 41 located on the distal end side of the second flange 43b and the first flange 43a.
- the head part 43 is inserted into the hollow part 33 of the gasket 3.
- An inwardly protruding engaging portion 34 is formed in the inner peripheral portion near the opening of the hollow portion 33 of the gasket 3, and the engaging portion 34 is formed of a first flange 43a and It is inserted between the second flange 43b.
- the method of connecting the gasket 3 and the pusher 4 (the pusher body 40) is not limited to the configuration shown in the figure, and may be connected by, for example, screwing, or by bonding or fusing together. It may be fixed.
- the base end side of the cylindrical portion 41 is formed by cutting off the upper and lower tube walls in the figure from the same cylinder as the cylindrical portion 41.
- Arm portion 46 is formed to protrude toward the base end direction.
- the pair of arms 46 are connected by a longitudinally extending rail 47 formed therebetween.
- the cross-sectional shape of the pair of arms 46 and the rails 47 is substantially H-shaped as a whole.
- convex portions 47a having a substantially right-angled triangular cross section are formed at the top and bottom in the figure. The slope of the projection 47a is directed toward the base end.
- convex portions 47b having a substantially right-angled triangular cross section are formed at upper and lower sides in the figure at intervals.
- the slope of the projection 47b (guide surface 47lb) is directed toward the tip.
- the convex part 4 7a and the convex part 4 7 Between them, a substantially quadrangular concave portion 48 is formed so as to be sandwiched between them.
- the guide surface 471b which is a slope of the convex portion 47b, has a function of guiding a convex portion 64 of the pusher operating portion 6 described later into the concave portion 48.
- the pusher operating portion 6 has a cylindrical portion 61 having a larger inner and outer diameter than the cylindrical portion 41 of the pusher body 40.
- a flange-shaped (plate-shaped) finger pad 62 is formed at the base end of the cylindrical part 61.
- a pair of upper and lower plate-like elastic pieces (arm portions) 63, 63 in the figure are formed to protrude toward the distal end from the finger contact portion 62 located inside the cylindrical portion 61, respectively. That is, the elastic pieces 63, 63 are located inside the cylindrical part 61. At the tips (opposite to the base) of the sex pieces 63, 63, approximately quadrangular convex portions 64, 64 projecting toward each other (inward), respectively, are formed.
- the convex portion 64 has a shape corresponding to the concave portion 48.
- such a pusher 4 is formed by inserting the rail portion 47 of the pusher body 40 between the both convex portions 64 of the pusher operating portion 6. , Both are in a state of being united.
- the size of the gap between the two convex portions 64 is almost the same as the width (thickness) of the rail portion 47.
- the pusher operating portion 6 is movable in the longitudinal direction with respect to the pusher body 40 by the double convex portions 64 sliding on the rail portions 47 while sandwiching the rail portions 47. By this movement, the length of the pusher 4 changes (expands or contracts) between a short state shown in FIG. 11 and a long state shown in FIG. Before the syringe 1 is used as shown in FIG.
- the presser 4 has a short length.
- the gasket 3 is located at a predetermined distance from the bottom 21 in the proximal direction, and a space 27 is formed at the distal end side of the gasket 3.
- the distal end portion (contact portion) 611 of the cylindrical portion 61 of the pusher operation portion 6 is in contact with the base end surface of the outer cylinder flange 25. It should be noted that the distal end portion 6 11 may be configured to be able to come into contact with another portion instead of the outer cylinder flange 25 as long as the portion is near the base end portion of the outer cylinder 2.
- the drug 100 (or powder from the beginning) that has collapsed and became powdery has an outer peripheral surface of the gasket 3 and an inner peripheral surface 2 of the body 20. It is possible to prevent entry into the gap with 0. Therefore, when administering the drug 100 using the syringe 1, the drug 100 that has entered the gap between the outer peripheral surface of the gasket 3 and the inner peripheral surface of the body portion 20 is a liquid sucked into the outer cylinder 2. If the drug is left undissolved in the drug, the dose of the drug 100 may be incorrect (less than the specified dose). It is possible to surely prevent such a situation.
- the length of the pusher 4 is variable, the total length of the syringe 1 before use shown in FIG. 11 can be reduced. Another advantage is that space can be reduced during transportation and storage of the syringe 1.
- the length of the pusher 4 is made longer in use as described below.
- the two convex portions 64 slide along the two guide surfaces 4 7 1 b, respectively.
- the amphoteric pieces 63 are elastically deformed so as to open by being guided and moved away from each other, the biconvex parts 6 4 respectively climb over the biconvex parts 4 7 b and the concave parts 4 8. It fits by inserting into the inside, and the state shown in FIG. 12 is obtained.
- the state where the two convex portions 64 are inserted and fitted into the two concave portions 48, respectively is maintained by the properties of the two elastic pieces 63. Can maintain (hold) its long state.
- the pusher operating section 6 is pulled from the state shown in FIG. 11 in the proximal direction and moved, and when the pusher 4 becomes long, the pusher body 40 and the pusher body 40 are pushed. Operability is extremely good because the child operation unit 6 is automatically locked (fixed). Further, in the present embodiment, the retaining means (the lock device) for maintaining the state where the length of the pusher 4 is long is maintained by the concave portion 48 (the convex portions 47 a and 47 b), the elastic piece 63 and the convex portion 64. ) Is composed.
- the same components as the elastic pieces 63 and the convex portions 64 are provided in the presser body 40, and the same components as the concave portions 48 are provided in the presser operating portion 6.
- Such a configuration may be adopted.
- the elastic pieces 63, the convex portions 64, and the concave portions 48 are provided on both the upper and lower sides in the figure, but the configuration is such that these are provided only on one side. There may be.
- the gasket 3 is connected to the tip of the body 20 of the outer cylinder 2 (the bottom 2 1 ). That is, in the state where the length of the pusher 4 is long, when the distal end surface of the gasket 3 contacts (or approaches) the inner surface of the bottom portion 21, the distal end portion 6 1 1 of the cylindrical portion 6 1 Does not touch the base end face of
- the method described below is an example in which a syringe with a double-ended needle is connected to the syringe 1 and a drug solution is co-injected into an infusion container.
- the holder 7 connected to the syringe 1 is a double-ended needle (needle tube) having a bottomed cylindrical holder body 71 and sharp needle tips 73, 74 at both ends. 7 and a hub (support member) 75 that supports the double-ended needle 72.
- the double-ended needle 72 is fixed to a hub 75, and the hub 75 is attached to the center of the bottom of the holder body 71 by screwing.
- the infusion container 8 is in the form of a bottle (bottle) or a bag, 82 is stored liquid-tight.
- a stopper 81 made of an elastic material is attached to the mouth of the infusion container 8.
- the infusion container 8 is liquid-tightly sealed by the stopper 81.
- the plug 81 can be pierced by a double tube with a double-ended needle 72, a bottle needle, or the like, and when the tube is removed, the piercing hole is closed due to self-occluding property to ensure liquid tightness.
- the holder body 71 of the holder 7 is fitted (covered) to the cap 12.
- the needle tip 73 penetrates the membrane 11 and enters the lumen 23 of the reduced diameter portion 22 (see FIG. 12A).
- the space 27 of the syringe 1 and the internal space of the infusion container 8 communicate with each other via the double-ended needle 72.
- the piercing of the needle tip 74 into the plug 81 and the piercing of the needle tip 73 into the membrane 11 may be performed in the reverse order.
- the syringe 1 is shaken or vibrated to dissolve or disperse the drug 100 in the infusion solution 82 introduced into the space 27, thereby obtaining a drug solution 110 containing the active ingredient of the drug 100 (see FIG. 13). ).
- a drug solution 110 containing the active ingredient of the drug 100
- the chemical solution 110 a solution, a suspension (emulsion), and the like of the chemical 100 are exemplified.
- the syringe 1 may be detached from the holder 7 once, and then the syringe 1 may be shaken or vibrated.
- the chemical solution 110 is obtained, the pusher 4 is pressed in the distal direction, and the gasket 3 is slid in the distal direction.
- the drug solution 110 in the space 27 is discharged through the double-ended needle 72 and is mixed with the infusion solution 82 in the infusion container 8 (see FIG. 14).
- the pressing movement of the pusher 4 is performed until the distal end surface of the gasket 3 contacts (or approaches) the bottom 21 of the outer cylinder 2.
- the remaining amount of the chemical solution 110 in the syringe 1 can be reduced as much as possible, and the prescribed amount of the chemical solution 100 can be accurately compounded.
- the syringe (prefilled syringe) according to the second embodiment of the present invention has been described above with reference to the embodiment shown in the drawings.
- the present invention is not limited to this, and each part constituting the syringe exhibits a similar function. It can be replaced with any configuration that can be used. Also, an arbitrary component may be added.
- the configuration of the mouth at the distal end of the outer cylinder is not limited to the configuration shown in the drawings.
- a device having no membrane for sealing the mouth or a device having an injection needle attached to the mouth is used. It may be.
- the pusher may have any structure as long as its length is variable.
- the pusher may have a main body in which plate pieces are crossed so as to have a cross-shaped cross section.
- the first aspect particularly the aspect having a hollow pusher structure provided with a filter, and the extendable pusher structure according to the second invention are provided, and the first to third aspects of the present invention are provided.
- FIGS. 1-10 An example of a preferred embodiment that achieves all of the objects described above is shown in FIGS.
- FIG. 15 is a longitudinal sectional view showing the disassembled state of the syringe (prefilled syringe) according to this embodiment
- FIG. 16 is a longitudinal sectional view showing the assembled state (before use) of the syringe shown in FIG. Fig. 17,
- Fig. 17 is a vertical cross-sectional view showing the assembled state of the syringe shown in Fig. 15 (in use)
- Fig. 18 is a vertical cross-sectional view showing the vicinity of the gasket in the syringe shown in Fig. 17
- FIG. 19 is an enlarged longitudinal sectional view showing the vicinity of the base end of the outer cylinder in the syringe shown in FIG.
- FIGS. 1 is a longitudinal sectional view showing the disassembled state of the syringe (prefilled syringe) according to this embodiment
- FIG. 16 is a longitudinal sectional view showing the assembled state (before use) of the syringe shown in FIG. Fig. 17
- the left side in the figures is the “distal end” side of the syringe, and the right side is the “base end” side.
- the same reference numerals as those in FIGS. 1 to 14 indicate the same or corresponding parts, and in the following, the description of the same matters as those in the first and second inventions may be omitted. .
- the present embodiment is a substantially similar syringe except that the point mainly having the sealing member 5 and the filter 9 is different from the embodiment of the second invention shown in FIGS. 9 to 14, and is similar to the second invention.
- the description of the items described above is omitted, and the points that are different from those in Figs.
- the syringe 1 of the present embodiment is a pre-filled syringe containing the drug 100 previously aseptically stored (enclosed) in the first space 27 of the outer cylinder 2, and comprises the outer cylinder 2 and the outer cylinder 2.
- a gasket 3 slidable inside, a pusher (plunger rod) 4 for moving the gasket 3 in the longitudinal direction of the outer cylinder 2, and a sealing member for sealing the base opening 201 of the outer cylinder 2.
- the sealing member 5 is arranged on the inner peripheral side of the hole 25 1 of the outer cylinder flange 25, and the base end opening 201 of the outer cylinder 2 is Seal airtightly with outer periphery of 40.
- the entirety of the sealing member 5 is made of an elastic material as exemplified in the first invention, and a sliding portion 41 of a main body 40 of the pusher 4 to be described later passes through a central portion thereof.
- An insertion hole 51 is formed.
- a ring-shaped convex portion 52 projecting from the inner surface of the insertion hole 51 toward the center is formed on the inner periphery of the insertion hole 51 over the entire circumference.
- the convex portion 52 slides while closely contacting the outer peripheral surface of the sliding portion 41 of the pusher 4 to ensure airtightness.
- the outer peripheral surface of the sealing member 5 is airtightly adhered to the inner peripheral surface of the hole 25 1 of the outer cylinder flange 25, and the inner peripheral surface 2 of the base end opening 201 of the outer cylinder 2. It is also tightly adhered to 0 0. Thereby, the sealing member 5 can substantially hermetically seal the proximal end opening 201 of the outer cylinder 2.
- Such a sealing member 5 is formed by two-color molding using an elastic material forming the sealing member 5 and a relatively hard material forming the outer cylinder flange 25, thereby forming the outer cylinder flange 25. It is preferable that it is integrally formed. Thus, the sealing member 5 can be easily manufactured, and the syringe 1 can be easily assembled. By installing such a sealing member 5, since the outside air does not enter the outer cylinder 2 and the outside air does not contact the inner peripheral surface 200, the sterility in the outer cylinder 2 can be maintained at a high level. Can be.
- the sealing member 5 also has a function of preventing a gasket 3 and a pusher 4 described later from falling out of the outer cylinder 2.
- the sealing member 5 may be manufactured separately and attached to the base opening 201 of the outer cylinder 2. Further, the entirety of the sealing member 5 may not be made of an elastic material, as long as at least a portion near the through hole 51 is made of an elastic material.
- a gasket 3 made of the same elastic material as in the second invention is accommodated in the outer cylinder 2.
- the medicine 100 is stored in advance in a second space 27 surrounded by the outer cylinder 2 located on the distal end side of the gasket 3 and the gasket 3. ing.
- a pusher 4 for moving the gasket 3 in the longitudinal direction in the outer cylinder 2 is connected (mounted) to the gasket 3.
- the presser 4 has a main body (presser main body) 40.
- the main body 40 has a sliding portion 41. As described above, the outer peripheral surface of the sliding portion 41 slides while being in close contact with the convex portion 52 of the sealing member 5.
- a first flange 43 a having a flange shape and a second flange 43 b located near the base end of the first flange 43 a are formed at the distal end of the sliding part 41.
- the head portion 43 is constituted by the portion of the sliding portion 41 located on the distal end side of the second flange 43 b and the first flange 43 a. As shown in FIG. 18, the head portion 43 is inserted into the hollow portion 33 of the gasket 3. An engagement portion 34 protruding inward is formed on the inner periphery near the opening of the hollow portion 33 of the gasket 3. The engaging portion 34 is inserted between the first flange 43a and the second flange 43b. As a result, the engaging portion 34, the first flange 43a and the second flange 43b are engaged, and the gasket 3 and the pusher 4 (the main body 40) are connected. Has become.
- a base opening portion 411 that opens to the outside is formed at the base end of the sliding portion 41.
- a distal end opening 4 12 is formed at the distal end of the sliding portion 41. That is, the distal end opening portion 4 12 is located inside the hollow portion 33 of the gasket 3.
- the inner space of the sliding portion 41 communicates the space between the outer cylinder 2 located on the base end side of the gasket 3, the gasket 3, and the sealing member 5, and the outside. It functions as a ventilation path (flow path) 4 13.
- a notch is formed in a part of the first flange 43a and the second flange 43b in the circumferential direction to provide a location where the gap between the head 43 and the gasket 3 is large, and the flow path is It may be enlarged.
- a filter 9 that allows gas to pass therethrough but does not allow bacteria to pass through is provided in the distal end opening 4 12 of the sliding portion 4 1, and is positioned so as to block the air passage 4 13.
- the outer peripheral portion of the filter 9 is entirely bonded to the leading end opening portion 4 12 by, for example, a method such as fusion (heat fusion, high frequency fusion, ultrasonic fusion, etc.) or adhesion (adhesion with an adhesive or a solvent). It is fixed around the circumference.
- the filter 9 may be installed in the middle of the sliding portion 41 (air passage 4 13), the filter 9 can be easily manufactured (assembled) by installing the filter 9 in the distal end opening 4 12. Can be.
- the location where the end opening of the ventilation path 4 13 is formed may not be the location located in the hollow portion 33 of the gasket 3.
- a side hole is formed in the pipe wall near the base end of the second flange 43 b of the sliding portion 41 so that the air passage 41 and the space 26 communicate with each other through this side hole. Configuration may be used.
- the tip of the sliding portion 41 may be sealed.
- a pair of cylinders formed by cutting out the upper and lower tube walls in the figure from the same cylinder as the sliding portion 41 are formed.
- the arm portion 46 is formed so as to protrude toward the base end.
- the pair of arms 46 are connected by a rail 47 extending in the longitudinal direction formed therebetween.
- the cross section of the pair of arms 46 and the rails 47 is substantially H-shaped as a whole.
- a substantially right-angled triangular convex portion 47a is formed at the top and bottom in the figure, respectively.
- the slope of the projection 47a is directed toward the base end.
- a substantially right-angled triangular convex portion 47b is formed at an interval above and below in the drawing.
- the slope of the projection 47b is directed toward the tip.
- a substantially rectangular concave portion 48 is formed between the convex portion 47a and the convex portion 47b so as to be sandwiched therebetween.
- the pusher 4 includes such a main body 40, and an operation unit (pusher operation unit) provided on the base end side of the main body 40 so as to be movable in the longitudinal direction of the presser 4.
- the length (total length) is variable (expandable).
- the structure and expansion and contraction of the pusher 4 composed of the main body 40 and the operation unit 6 are the same as those of the second invention, and a description thereof will be omitted. Due to the movement of the operation unit 6, the length of the pusher 4 changes (extends and contracts) between a short state shown in FIG. 16 and a long state shown in FIG.
- variable length of the pusher 4 reduces the overall length of the syringe 1 before using the syringe 1 shown in Fig. 16 and reduces the space during transportation and storage of the syringe 1. can do.
- the operation unit 6 is moved in the proximal direction with respect to the main body unit 40 from the state shown in FIG. 16, the two convex portions 64 slide along the slopes of the two convex portions 47 b, respectively. While the elastic pieces 63 are elastically deformed so as to open, the two convex parts 64 are respectively inserted (fitted) into the two concave parts 48 over the two convex parts 47b, as shown in FIG. It becomes.
- the pusher 4 can maintain (hold) its long length by the engagement (fitting) between the two convex portions 64 and the two concave portions 48.
- the protrusions 47 a and 47 b, the recesses 48, and the elastic pieces 63 constitute a maintenance means for maintaining the state in which the length of the pusher 4 is long.
- the presser 4 has a short length, and the gasket 3 is located on the proximal end side of the medicine 100.
- the distal end of the operating section 6 (cylindrical section 61) abuts on the base end surface of the sealing member 5 (or the outer cylindrical flange 25).
- the gasket 3 cannot be moved further in the distal direction, and the gasket 3 cannot be pushed down to the distal end (bottom 21) of the body 20 of the outer cylinder 2.
- the drug 100 can be stored without breaking its shape, and the beauty of the product can be reliably maintained.
- the collapsed and powdered medicine 100 is formed between the outer peripheral surface of the gasket 3 and the inner peripheral surface 200 of the outer cylinder 2. May get in between. In that case, the infusion is then inhaled to dissolve the drug 100. Even when the gasket 3 is released, the drug 100 that has entered between the outer peripheral surface of the gasket 3 and the inner peripheral surface 200 of the outer cylinder 2 remains without melting, and as a result, the dose of the drug 100 becomes inconsistent. However, in the present embodiment, it is possible to reliably prevent such a situation from occurring.
- the gasket 3 can be moved in the distal direction before use, when the pusher 4 is erroneously pressed, especially when the drug 100 is a liquid, the liquid ( The pressure of the chemical (100) increases, and the liquid breaks the membrane (11) and leaks from the reduced diameter portion (22), or the liquid flows from the space between the inner peripheral surface (200) of the outer cylinder (2) and the gasket (3) to the space (26). It may leak. On the other hand, in the present embodiment, such a situation can be reliably prevented.
- the length of the pusher 4 when used, as shown in FIG. 17, by setting the length of the pusher 4 to be long, the length of the pusher 4 becomes sufficiently long.
- the gasket 3 can be pushed all the way to the tip (bottom 21) of the body 20 of the outer cylinder 2. That is, when the pusher 4 is further pressed and moved in the distal direction from the state shown in FIG. 17, the distal end surface of the gasket 3 comes into contact with (abuts) the inner surface of the bottom portion 21 and the operating portion 6 (the cylindrical portion) The distal end of 6 1) does not contact (abut) the proximal end surface of the sealing member 5 (or the outer flange 25).
- the presser 4 may have a variable length.
- the method of using the syringe 1 of the present embodiment is basically the same as [1] to [4] described as an example in which a drug solution is co-injected into an infusion container (not shown) in the second invention.
- the syringe according to the present invention has been described for each of the illustrated embodiments, but the present invention is not limited to these embodiments.
- the components of the syringe, in particular, the configuration of the pusher, gasket, sealing member, ventilation means, and the like are not limited to those shown in the drawings, but may be any components that can exhibit the same function. Also, an arbitrary component may be added.
- the present invention has been described based on the example of the embodiment of the prefilled syringe.
- the syringe of the present invention is not limited to the prefilled syringe, and may be an ordinary syringe having no pre-stored drug. .
- the syringe structure of the present invention it is possible to ensure hygiene inside the syringe outer cylinder when not in use, and to easily perform operations such as discharge (injection) of a chemical solution. And excellent operability.
- the operation of the pusher that pushes and pulls the pusher can be performed with a light force, and even if the gasket is slid in the distal direction and the proximal direction, the internal sterility can be reliably maintained.
- the prefilled syringe of the present invention has a high internal sterility retention and is excellent in hygiene and safety.
- the gasket when the pusher is in a short state, the gasket can be prevented from moving in the distal end direction even if the pusher is pressed. Therefore, a system in which the medicine is stored in advance in a space surrounded by the distal end surface of the gasket and the outer cylinder.
- the gasket When applied to a syringe, even if the pusher is pressed by some force before use, the gasket does not move in the direction of the tip, ensuring that the adverse effects associated with the movement of the gasket will occur. Can be prevented.
Landscapes
- Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
Description
Claims
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT03741151T ATE552873T1 (de) | 2002-07-02 | 2003-07-02 | Spritze und vorgefüllte spritze |
| EP03741151A EP1530978B1 (en) | 2002-07-02 | 2003-07-02 | Syringe and prefilled syringe |
| AU2003281199A AU2003281199A1 (en) | 2002-07-02 | 2003-07-02 | Syringe and prefilled syringe |
| US10/519,705 US7081107B2 (en) | 2002-07-02 | 2003-07-02 | Syringe and prefilled syringe |
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002-194010 | 2002-07-02 | ||
| JP2002194010A JP4010890B2 (ja) | 2002-07-02 | 2002-07-02 | シリンジ |
| JP2002218140A JP4010900B2 (ja) | 2002-07-26 | 2002-07-26 | シリンジ |
| JP2002-218140 | 2002-07-26 | ||
| JP2002266000A JP4050579B2 (ja) | 2002-09-11 | 2002-09-11 | プレフィルドシリンジ |
| JP2002-266000 | 2002-09-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2004004811A1 true WO2004004811A1 (ja) | 2004-01-15 |
Family
ID=30118908
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2003/008413 Ceased WO2004004811A1 (ja) | 2002-07-02 | 2003-07-02 | シリンジおよびプレフィルドシリンジ |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US7081107B2 (ja) |
| EP (2) | EP1530978B1 (ja) |
| AT (1) | ATE552873T1 (ja) |
| AU (1) | AU2003281199A1 (ja) |
| WO (1) | WO2004004811A1 (ja) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10195350B2 (en) | 2011-08-31 | 2019-02-05 | Abbvie Inc. | Sealing arrangement for syringe |
Families Citing this family (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004004811A1 (ja) | 2002-07-02 | 2004-01-15 | Terumo Kabushiki Kaisha | シリンジおよびプレフィルドシリンジ |
| FR2848182B1 (fr) | 2002-12-04 | 2006-02-03 | Eurocrystal | Procede et dispositif d'emballage sterile d'une lentille intraoculaire hydrophile souple prete a l'emploi |
| US7998106B2 (en) | 2004-05-03 | 2011-08-16 | Thorne Jr Gale H | Safety dispensing system for hazardous substances |
| US7727195B2 (en) * | 2004-07-01 | 2010-06-01 | West Pharmaceutical Services, Inc. | Syringe device having venting system |
| US7905868B2 (en) | 2006-08-23 | 2011-03-15 | Medtronic Minimed, Inc. | Infusion medium delivery device and method with drive device for driving plunger in reservoir |
| JP4941303B2 (ja) * | 2005-08-22 | 2012-05-30 | ニプロ株式会社 | プレフィルドシリンジ |
| US20080114307A1 (en) * | 2006-11-06 | 2008-05-15 | Jeffrey Smith | Puncturable membrane for safety syringe |
| DK1894590T3 (da) * | 2006-08-30 | 2012-07-23 | Hoffmann La Roche | Injektionsindretning med forenklet tilbageholdelse af en prop |
| JP5102350B2 (ja) | 2007-04-30 | 2012-12-19 | メドトロニック ミニメド インコーポレイテッド | リザーバ充填/気泡管理/注入媒体送給システムおよび該システムを用いる方法 |
| US7963954B2 (en) | 2007-04-30 | 2011-06-21 | Medtronic Minimed, Inc. | Automated filling systems and methods |
| EP2167172B1 (en) * | 2007-06-04 | 2019-03-06 | Becton, Dickinson and Company | Stopper and plunger rod for a pre-filled syringe |
| US8740856B2 (en) * | 2007-06-04 | 2014-06-03 | Becton, Dickinson And Company | Stoppers used in pre-filled syringes |
| US8192393B2 (en) | 2008-10-07 | 2012-06-05 | Christcot Medical Company | Method and apparatus for inserting a rectal suppository |
| US9662481B2 (en) | 2008-10-07 | 2017-05-30 | Cristcot Llc | Method and apparatus for inserting a rectal suppository |
| ES2719496T3 (es) | 2008-11-12 | 2019-07-10 | Medimmune Llc | Formulación de anticuerpo |
| JP5517950B2 (ja) * | 2008-12-03 | 2014-06-11 | 電気化学工業株式会社 | シリンジ |
| GB2467904B (en) * | 2009-02-17 | 2013-06-12 | Oval Medical Technologies Ltd | Drug container and delivery mechanism |
| DE102009023334A1 (de) | 2009-05-29 | 2010-12-02 | Lts Lohmann Therapie-Systeme Ag | Zur Lagerung von Injektionslösungen geeignete Zylinder-Kolben-Einheit für einen nadelfreien Injektor und Verfahren zum blasenfreien automatischen oder manuellen Befüllen der Zylinder-Kolben-Einheit, auch bei Atmosphärendruck |
| CN102639174B (zh) * | 2009-09-30 | 2014-04-09 | 泰尔茂株式会社 | 预充式注射器 |
| JPWO2011108575A1 (ja) * | 2010-03-05 | 2013-06-27 | テルモ株式会社 | 医療器具 |
| WO2012022734A2 (en) | 2010-08-16 | 2012-02-23 | Medimmune Limited | Anti-icam-1 antibodies and methods of use |
| CN103415313B (zh) | 2011-03-01 | 2017-06-13 | 泰尔茂株式会社 | 注射器及注射器组装体 |
| DE102011016977A1 (de) * | 2011-04-15 | 2012-10-18 | Sartorius Stedim Biotech Gmbh | Inokulationsspritze |
| US20120265140A1 (en) * | 2011-04-18 | 2012-10-18 | Thorne Consulting And Intellectual Property, Llc | Medical syrnge prime and cross-contamination free devices |
| US8657793B2 (en) | 2011-09-30 | 2014-02-25 | Becton Dickinson France, S.A.S | Space saving plunger cap and rod assembly |
| WO2013158273A1 (en) | 2012-04-20 | 2013-10-24 | Abbvie Inc. | Methods to modulate c-terminal lysine variant distribution |
| US9249182B2 (en) | 2012-05-24 | 2016-02-02 | Abbvie, Inc. | Purification of antibodies using hydrophobic interaction chromatography |
| US8870028B2 (en) | 2012-05-25 | 2014-10-28 | Restek Corporation | Dispensing device |
| GB201210082D0 (en) * | 2012-06-07 | 2012-07-25 | Consort Medical Plc | Improved syringe |
| EP2908793B1 (en) | 2012-10-19 | 2017-04-26 | Cristcot LLC | Suppository insertion device, suppository, and method of manufacturing a suppository |
| ES2988501T3 (es) | 2012-12-03 | 2024-11-20 | Novobiotic Pharmaceuticals Llc | Nuevo depsipéptido y usos del mismo |
| JP6040025B2 (ja) * | 2012-12-28 | 2016-12-07 | 株式会社大協精工 | 医療用の注射器 |
| EP2970375A1 (en) | 2013-03-14 | 2016-01-20 | AbbVie Inc. | Low acidic species compositions and methods for producing the same using displacement chromatography |
| SG11201504260UA (en) | 2013-03-14 | 2015-10-29 | Abbvie Inc | Low acidic species compositions and methods for producing and using the same |
| EP4137139A1 (en) | 2013-07-10 | 2023-02-22 | Matrix Biology Institute | Compositions of hyaluronan with high elasticity and uses thereof |
| WO2015050959A1 (en) | 2013-10-01 | 2015-04-09 | Yale University | Anti-kit antibodies and methods of use thereof |
| US9775950B2 (en) | 2014-01-14 | 2017-10-03 | Parenteral Technologies, Llc | Syringe with dosage indicator for the visually impaired |
| US9827376B2 (en) | 2014-01-29 | 2017-11-28 | Becton, Dickinson And Company | Plunger assembly including a plunger rod for advancing a stopper through a syringe |
| JP6496303B2 (ja) * | 2014-03-28 | 2019-04-03 | テルモ株式会社 | 包装されたプレフィルドシリンジ |
| US20170226552A1 (en) | 2014-07-03 | 2017-08-10 | Abbvie Inc. | Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using cobalt |
| WO2016007764A1 (en) | 2014-07-09 | 2016-01-14 | Abbvie Inc. | Methods for modulating the glycosylation profile of recombinant proteins using non-commonly used sugars |
| WO2016144773A1 (en) | 2015-03-06 | 2016-09-15 | Abbvie Inc. | Arabinosylated glycoproteins |
| IL239366B (en) | 2015-06-11 | 2018-07-31 | Kriheli Marino | Components of a fluid transfer apparatus |
| PL3352766T3 (pl) | 2015-09-24 | 2021-08-02 | Matrix Biology Institute | Kompozycie z hialuronanem o dużej elastyczności i sposoby ich użycia |
| WO2017147003A1 (en) | 2016-02-26 | 2017-08-31 | Novobiotic Pharmaceuticals, Llc | Novel macrocyclic antibiotics and uses thereof |
| MX2018013823A (es) | 2016-05-12 | 2019-07-08 | Cristcot Llc | Dispositivo y metodo de insercion de supositorio de un solo uso. |
| US10898658B2 (en) | 2016-07-06 | 2021-01-26 | LynJohnston, LLC | Compact injection device with telescoping components |
| CN110612306B (zh) | 2017-04-04 | 2024-05-07 | 诺沃生物医药有限责任公司 | 新缩肽类及其用途 |
| AU2019206534B2 (en) | 2018-01-10 | 2025-01-30 | LynJohnston, LLC | Compact injector systems and methods |
| CN109464282B (zh) * | 2019-01-03 | 2020-12-04 | 苏州大学附属儿童医院 | 一种易配药注射器 |
| CN112827018B (zh) * | 2019-01-15 | 2022-07-26 | 温州医科大学附属第二医院(温州医科大学附属育英儿童医院) | 一种使用过程防气流污染的医用注射器 |
| DK180893B1 (en) * | 2020-04-21 | 2022-06-14 | Region Sjælland | Stool sample device |
| WO2023150829A1 (en) * | 2022-02-11 | 2023-08-17 | Haemograph Pty Ltd | Vented piston |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS53115681U (ja) * | 1977-02-23 | 1978-09-14 | ||
| EP0304386A2 (fr) * | 1987-05-22 | 1989-02-22 | Rovira Mestres, Ramon | Seringue pour l'injection de fluides, comprenant un mécanisme la rendant non réutilisable |
| JPH01254169A (ja) * | 1988-04-01 | 1989-10-11 | Terumo Corp | プロテクター付注射装置 |
| JPH0391353U (ja) * | 1989-12-29 | 1991-09-18 | ||
| EP0526824A2 (en) * | 1991-08-07 | 1993-02-10 | Becton, Dickinson and Company | Syringe sprayer |
| WO1995011711A1 (en) * | 1993-10-29 | 1995-05-04 | Pharmacia Ab | Improvements in injection devices |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US404105A (en) * | 1889-05-28 | Martin overlaci-i | ||
| JPS53115681A (en) | 1977-03-19 | 1978-10-09 | Nitto Electric Ind Co Ltd | Method for manufacturing reverse permeative separation tube |
| US4632672A (en) * | 1985-10-07 | 1986-12-30 | Minnesota Mining And Manufacturing Company | Self venting syringe plunger |
| US4813938A (en) * | 1987-09-17 | 1989-03-21 | Raulerson J Daniel | Catheter introduction syringe |
| GB2226606B (en) | 1988-12-08 | 1993-05-05 | Astra Tech Ab | Positive displacement pump |
| JPH0391353A (ja) | 1989-09-04 | 1991-04-16 | Hitachi Ltd | チャネルの接続切断管理方式および装置 |
| CA2016870C (en) * | 1990-05-15 | 1994-03-29 | Arnie Drudik | Dispenser for storing and mixing several components |
| US5330443A (en) * | 1993-04-20 | 1994-07-19 | Powles Trevor J | Aspiration needle, syringe for use therewith, apparatus incorporating the same and kit for use in fine needle aspiration cytology |
| JPH07246238A (ja) | 1994-03-09 | 1995-09-26 | Daikyo Seiko:Kk | 注射器組立体 |
| WO2004004811A1 (ja) | 2002-07-02 | 2004-01-15 | Terumo Kabushiki Kaisha | シリンジおよびプレフィルドシリンジ |
-
2003
- 2003-07-02 WO PCT/JP2003/008413 patent/WO2004004811A1/ja not_active Ceased
- 2003-07-02 AU AU2003281199A patent/AU2003281199A1/en not_active Abandoned
- 2003-07-02 EP EP03741151A patent/EP1530978B1/en not_active Expired - Lifetime
- 2003-07-02 US US10/519,705 patent/US7081107B2/en not_active Expired - Fee Related
- 2003-07-02 EP EP11174972A patent/EP2386326B1/en not_active Expired - Lifetime
- 2003-07-02 AT AT03741151T patent/ATE552873T1/de active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS53115681U (ja) * | 1977-02-23 | 1978-09-14 | ||
| EP0304386A2 (fr) * | 1987-05-22 | 1989-02-22 | Rovira Mestres, Ramon | Seringue pour l'injection de fluides, comprenant un mécanisme la rendant non réutilisable |
| JPH01254169A (ja) * | 1988-04-01 | 1989-10-11 | Terumo Corp | プロテクター付注射装置 |
| JPH0391353U (ja) * | 1989-12-29 | 1991-09-18 | ||
| EP0526824A2 (en) * | 1991-08-07 | 1993-02-10 | Becton, Dickinson and Company | Syringe sprayer |
| WO1995011711A1 (en) * | 1993-10-29 | 1995-05-04 | Pharmacia Ab | Improvements in injection devices |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10195350B2 (en) | 2011-08-31 | 2019-02-05 | Abbvie Inc. | Sealing arrangement for syringe |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1530978A1 (en) | 2005-05-18 |
| EP1530978A4 (en) | 2010-05-26 |
| ATE552873T1 (de) | 2012-04-15 |
| US7081107B2 (en) | 2006-07-25 |
| EP1530978B1 (en) | 2012-04-11 |
| EP2386326A1 (en) | 2011-11-16 |
| EP2386326B1 (en) | 2013-01-09 |
| US20050240159A1 (en) | 2005-10-27 |
| AU2003281199A1 (en) | 2004-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2004004811A1 (ja) | シリンジおよびプレフィルドシリンジ | |
| EP0609741B1 (en) | Prefilled syringe assembly | |
| JP5003155B2 (ja) | プレフィルドシリンジ | |
| JP4829243B2 (ja) | 薬剤を凍結乾燥し、元に戻し、かつ元に戻した薬剤を投与する方法および装置 | |
| JP4682850B2 (ja) | プレフィルドシリンジ | |
| US9731076B2 (en) | Multi-compartment pre-filled mixing syringes with bypass | |
| JP2001112867A (ja) | 薬剤入りシリンジ | |
| CZ288168B6 (en) | Syringe | |
| JP2007185319A5 (ja) | ||
| JP3811005B2 (ja) | 医療用容器 | |
| JPWO1999006089A1 (ja) | 医療用容器 | |
| JP4010890B2 (ja) | シリンジ | |
| JPH09299484A (ja) | シリンジ・スプレーポンプ | |
| JP4050579B2 (ja) | プレフィルドシリンジ | |
| JPH1147273A (ja) | 薬液注入器具 | |
| JP4144027B2 (ja) | 2成分混合タイプのプレフィルドシリンジ | |
| JPH0928764A (ja) | 注入容器 | |
| JP4010900B2 (ja) | シリンジ | |
| JP2006116223A (ja) | プレフィルドシリンジ | |
| JP4144026B2 (ja) | 2成分混合型プレフィルドシリンジ | |
| JP3688629B2 (ja) | 注射器 | |
| JPH0759865A (ja) | 注入容器 | |
| JP4152103B2 (ja) | プレフィルドシリンジ | |
| JP2003199825A (ja) | プレフィルドシリンジ | |
| JP2011212361A (ja) | 薬剤投与具 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| WWE | Wipo information: entry into national phase |
Ref document number: 2003741151 Country of ref document: EP Ref document number: 10519705 Country of ref document: US |
|
| WWP | Wipo information: published in national office |
Ref document number: 2003741151 Country of ref document: EP |